Yarema Kristin 4
4 · Poseida Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Yarema Kristin
President and CEO
Transactions
- Award
Common Stock
2024-01-02+250,000→ 606,836 total - Award
Stock Option (Right to buy)
2024-01-02+345,200→ 345,200 totalExercise: $3.38Exp: 2034-01-01→ Common Stock (345,200 underlying)
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest in four equal annual installments beginning from the first anniversary of January 1, 2024.
- [F2]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of January 1, 2024, and the remaining shares will vest in 42 equal monthly installments thereafter.